These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 313218)

  • 1. Studies on factor VIII-related protein. I. Ultrastructural and electrophoretic heterogeneity of human factor VIII-related protein.
    Beck EA; Tranqui-Pouit L; Chapel A; Perret BA; Furlan M; Hudry-Clergeon G; Suscillon M
    Biochim Biophys Acta; 1979 May; 578(1):155-63. PubMed ID: 313218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on factor VIII-related protein. II. Estimation of molecular size differences between factor VIII oligomers.
    Perret BA; Furlan M; Beck EA
    Biochim Biophys Acta; 1979 May; 578(1):164-74. PubMed ID: 454664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electron microscopy of human factor VIII/Von Willebrand glycoprotein: effect of reducing reagents on structure and function.
    Ohmori K; Fretto LJ; Harrison RL; Switzer ME; Erickson HP; McKee PA
    J Cell Biol; 1982 Nov; 95(2 Pt 1):632-40. PubMed ID: 6815213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disulfide bonds and the quaternary structure of factor VIII/von Willebrand factor.
    Counts RB; Paskell SL; Elgee SK
    J Clin Invest; 1978 Sep; 62(3):702-9. PubMed ID: 308512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on human antihemophilic factor. Evidence for a covalently linked subunit structure.
    Switzer ME; McKee PA
    J Clin Invest; 1976 Apr; 57(4):925-37. PubMed ID: 1084890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fractionation of individual, biologically active factor VIII multimers.
    Perret BA; Furlan M; Kneubuehl F; Beck EA
    Biochim Biophys Acta; 1981 Jun; 669(1):98-104. PubMed ID: 6794637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Von Willebrand activity of low molecular weight human Factor VIII increases by binding to gold granules.
    Furlan M; Perret BA; Beck EA
    Thromb Haemost; 1981 Jun; 45(3):242-6. PubMed ID: 6792738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets.
    Ruggeri ZM; Zimmerman TS
    J Clin Invest; 1980 Jun; 65(6):1318-25. PubMed ID: 6773982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theoretical approach to molecular biology of factor VIII: heterogeneity of the molecule.
    Gralnick HR; Marchesi SL; Coller BS
    Ann N Y Acad Sci; 1975 Jan; 240():378-88. PubMed ID: 1078621
    [No Abstract]   [Full Text] [Related]  

  • 10. Partial purification of biologically active, low molecular weight, human antihemophilic factor free of Von Willebrand factor. I. Partial characterization and evidence for disulfide bond(s) susceptible to limited reduction.
    Harris RB; Newman J; Johnson AJ
    Biochim Biophys Acta; 1981 May; 668(3):456-70. PubMed ID: 6786356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease.
    Jenkins CS; Phillips DR; Clemetson KJ; Meyer D; Larrieu MJ; Lüscher EF
    J Clin Invest; 1976 Jan; 57(1):112-24. PubMed ID: 1081991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Is there a correlation between sugar content, thrombocyte aggregating activity and molecular size of factor VIII?].
    Furlan M; Perret BA; Beck EA
    Schweiz Med Wochenschr; 1979 Sep; 109(37):1369-70. PubMed ID: 314662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of purified rat factor VIII/von Willebrand factor with rat and human platelets--effect of albumin and ristocetin.
    Dejana E; Furlan M; Barbieri B; Donati MB; Beck EA
    Thromb Haemost; 1984 Aug; 52(1):57-9. PubMed ID: 6437011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of porcine and human ristocetin-Willebrand factor.
    Olson JD; Brockway WJ; Fass DN; Bowie EJ; Mann KG
    J Lab Clin Med; 1977 Jun; 89(6):1278-94. PubMed ID: 405441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease.
    Sultan Y; Simeon J; Caen JP
    J Lab Clin Med; 1976 Feb; 87(2):185-94. PubMed ID: 1082003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple molecular forms of endothelial cell factor VIII related antigen.
    Nachman RL; Jaffe EA; Ferris B
    Biochim Biophys Acta; 1981 Feb; 667(2):361-9. PubMed ID: 6783119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and properties of bovine factor VIII (antihemophilic factor).
    Vehar GA; Davie EW
    Biochemistry; 1980 Feb; 19(3):401-10. PubMed ID: 7356933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the human factor VIII procoagulant protein with a heterologous precipitating antibody.
    Fulcher CA; Zimmerman TS
    Proc Natl Acad Sci U S A; 1982 Mar; 79(5):1648-52. PubMed ID: 6803246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bernard-Soulier syndrome: a new platelet glycoprotein abnormality. Its relationship with platelet adhesion to subendothelium and with the factor VIII von Willebrand protein.
    Caen JP; Nurden AT; Jeanneau C; Michel H; Tobelem G; Levy-Toledano S; Sultan Y; Valensi F; Bernard J
    J Lab Clin Med; 1976 Apr; 87(4):586-96. PubMed ID: 1083883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some effects of calcium on the activation of human factor VIII/Von Willebrand factor protein by thrombin.
    Switzer ME; McKee PA
    J Clin Invest; 1977 Oct; 60(4):819-28. PubMed ID: 408379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.